EFFECT OF SUPPLEMENTATION OF WITHANIA COAGULANS FRUIT ON THE FASTING PLASMA GLUCOSE LEVELS OF TYPE 2 DIABETIC SUBJECTS by V, Hemalatha & Vigasini, Nora
Vol 11, Issue 12, 2018
Online - 2455-3891 
Print - 0974-2441
EFFECT OF SUPPLEMENTATION OF WITHANIA COAGULANS FRUIT ON THE FASTING PLASMA 
GLUCOSE LEVELS OF TYPE 2 DIABETIC SUBJECTS
HEMALATHA V, NORA VIGASINI*
Department of Home Science, Women’s Christian College, Chennai, Tamil Nadu, India. Email: nora.researchpub@gmail.com
Received: 21 May 2018, Revised and Accepted: 20 August 2018
ABSTRACT
Objective: The objective of this study is to determine the effect of supplementation of Withania coagulans fruit on the fasting plasma glucose (FPG) 
levels of type 2 diabetic subjects.
Methods: In the natural system of medicine, many plants have been claimed to be useful for the management of diabetes mellitus. W. coagulans 
(Paneer poo) is one such source in which the fruit of the plant possesses hypoglycemic properties. The study was designed to determine the effect of a 
60-day supplementation of W. coagulans fruit drink on the FPG levels of Type 2 diabetic subjects. W. coagulans fruit (6 numbers - approximately 2.5 g) 
was soaked overnight in 100 ml of water. This was administered to the experimental group. The control group received a placebo.
Results: There was a significant decrease in the FPG levels of the experimental group on the 61st day. There was a statistically significant increase in 
the FPG level of the control group on the 61st day, showing that the placebo did not have any hypoglycemic effect.
Conclusion: A significant reduction in FPG levels in the experimental group at the end of the study period proves that W. coagulans is a good 
hypoglycemic agent.
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INTRODUCTION
Diabetes mellitus is a chronic disease which has clinched the world. 
>300 million people of the world are suffering from this disease, and the 
number is still increasing at a rapid rate as modern medical science has no 
permanent solution for the disease [1]. It is a complicated and divergent 
metabolic disorder which in addition to blood sugar control requires the 
management of lipid parameters, blood pressure, and thrombotic factors. 
The treatment for diabetes is both difficult and tedious; it is expensive 
and unaffordable by majority of the population [2].
The current treatments for diabetes mellitus include the use of insulin and 
synthetic drugs. The long-term usage of modern drugs exhibits several 
side effects and complications to different organs of the body which 
ultimately lead to cardiovascular problems, liver disease, kidney disease, 
and weight gain too. These synthetic drugs are valuable but restricted by 
their side effects such as hypoglycemia, damage to the liver, lactic acidosis, 
diarrhea, abdominal pain, weight loss, and loss of appetite [2,3].
Due to the problems associated with the current treatments, a large 
percentage of diabetics resort to natural plant-based alternative 
remedies that are supposed to improve glycemic control. Hence, there 
is a need to screen more medicinal plants that have the advantage of 
being biodegradable, safe, and cheap with fewer side effects for their 
hypoglycemic activity [3].
The World Health Organization has pointed out that prevention of 
diabetes and its complications is a major global challenge. Therefore, 
in recent years, considerable attention has been directed toward 
identification of plants with antidiabetic ability that may be used for 
human consumption [4]. Withania coagulans (Paneer poo) is one 
such source, in which every part of the plant possesses therapeutic 
properties. It has many bioactive compounds that are responsible 
for its biological and pharmacological activities. Besides phenols, 
flavonoids, tannins, saponins, and alkaloids, the withanolides present 
in it are the major bioactive components that possess antimicrobial, 
anti-inflammatory, antitumor, hepatoprotective, antihyperglycemic, 
cardiovascular, immunosuppressive, and free radical scavenging 
properties. It is commonly available in herbal shops, less expensive 
with no reported side effects and toxicity [5,6].
Therefore, this study aimed at evaluating the role of W. coagulans fruit 
as an adjunct hypoglycemic agent which probably might throw some 
light on its potential use as a natural, cost-effective, and safe therapeutic 
alternative in the management of type 2 diabetes mellitus.
Objective of the study
The objective of this study is to determine the effect of supplementation 
of W. coagulans fruit drink on the fasting plasma glucose (FPG) levels of 
type 2 diabetic subjects.
METHODS
The approval of the Institutional Ethics Committee was obtained before 
the conduction of the study.
Design of the study
The research design adopted for this study was a pre-test, post-test 
experimental research design with control group. The study was carried 
out to determine the effect of supplementation of W. coagulans on the 
FPG levels of 12 type 2 diabetic subjects. Assessments were made on 
0th, 30th, and 61th days of study/supplementation. The same parameters 
were assessed among 12 other type 2 diabetic subjects who served as 
the control group. The control group received a placebo.
Selection of the sample
The subjects were selected based on purposive sampling. Both male 
and female type 2 diabetic subjects aged between 35 and 65 years were 
selected after an initial screening. The subjects were selected from 
North Chennai.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i12.27433
Research Article
449
Asian J Pharm Clin Res, Vol 11, Issue 12, 2018, 448-451
 Hemalatha and Vigasini 
Criteria for sample selection
Inclusion criteria
The following criteria were included in the study:






The following criteria were excluded from the study:
•	 Individuals	with	type	1	diabetes	mellitus.
•	 Individuals	with	complications	such	as	cancer,	thyrotoxicosis,	chronic	




Subjects were randomly assigned to either the control or the 
experimental groups that comprised of 12 subjects each (Fig. 1).
Orientation of the subjects
The subjects were briefed about the significance of the study by the 
investigator. They were instructed that blood would be collected 
in a 12-h fasting state to assess the FPG levels of the subjects. The 
subjects were requested to report between 6.30 am and 8.00 am in 
a 12-h fasting state for blood collection on the 0th day of the study/
supplementation period. The initial FPG levels of all the subjects were 
analyzed, and they were divided into two groups, namely, the control 
group and the experimental group. Both groups continued with their 
oral hypoglycemic drugs during the supplementation period.
Collection of blood sample
2 ml of blood was drawn from antecubital vein using a 2.5-mL sterile 
disposable syringe with 23-G × 1 needle. The blood was drawn from each 
subject and then transferred into separate fluoride tubes. It was mixed 
by inverting the tube 8–10 times. Then, the tubes were centrifuged at 
3000 rpm for 10 min. The plasma was aspirated and used for glucose 
analysis. This procedure was adopted for the initial screening (0th day) 
and repeated on the 30th and 61st days of supplementation.
Preparation of supplement
W. coagulans fruit can be used effectively in the long-term management 
of type 2 diabetes mellitus without any side effects. A supplementation 
of 10 g of W. coagulans for 3 months has been reported to be safe 
without any side effects or toxicity [8,9].
In this study, six fruits (around 2–2.5 g) of W. coagulans (paneer poo) 
were soaked overnight in 100 ml of water. In the morning, the fruits 
were squeezed into the water. The extract was filtered, and to this, 1 ml 
of tamarind extract was added and administered. A photograph of the 
W. coagulans drink (supplement) is shown in Fig. 2.
Preparation of placebo
As shown in Fig. 3, W. coagulans supplement had a yellowish to light 
brown tint. To give a similar appearance for the placebo that was 
administered to the control group, 1 ml of tamarind fruit pulp was 
added to 100 ml of water.
Control group




Subjects in the experimental group were instructed to take the 
supplement	every	morning	at	6.30	AM	in	an	empty	stomach.
RESULTS AND DISCUSSION
Effect of supplementation of W. coagulans on FPG levels of Type 2 
diabetic subjects
The FPG levels of subjects in the experimental and control groups 
assessed on the day before the commencement of supplementation 
(0th day), on the 30th day of supplementation, and on the day after the last 
day of supplementation (61st day) are presented in Table 1 and Fig. 4.
It can be observed from Table 1 that there was a significant decrease 
in the FPG levels in the experimental group on the 30th and 61st days. 
A highly significant reduction in FPG levels in the experimental group 
at the end of the study period proves that W. coagulans has a good 
hypoglycemic effect. This hypoglycemic effect of W. coagulans can be 
attributed to the bioactive compounds such as phenol, flavonoid, and 
withanolides present in it.
It is evident from Table 1 that there was a decrease in the mean FPG 
levels of the control group on the 30th day; however, this was not 
statistically significant. A different trend was observed after this period, 
where there was a statistically significant increase in the FPG level in 
the control group on the 61st day. This proves that the placebo did not 
have any hypoglycemic effect.
It has been reported that the hydroalcoholic extract of W. coagulans 
and the cold aqueous extract of W. coagulans exhibit antihyperglycemic 
activities in alloxan-induced diabetic rats [10].
Effect of supplementation on FPG Levels of subjects - experimental 
versus control group
A comparison of the FPG levels of the experimental and control group 
between the 0th and 61st days of the study is presented in Table 2.
On comparing the mean FPG levels of the experimental and control 
groups on the day before the commencement of supplementation 
(0th day), it was found that there was no statistically significant 
difference between the two groups.
However, at the end of the supplementation period (61st day), there 
was a statistically significant difference between the experimental 
Fig. 1: Sample size Fig. 2: Withania coagulans fruit drink (supplement)
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and control groups. The experimental group showed a decrease while 
the control group showed an increase in the FPG levels that were 
statistically significant.
It has been reported that W. coagulans (Doda Paneer) not only lowers 
the blood sugar level but also minimizes the future complications 
of diabetes such as neuropathy, retinopathy, nephropathy, and 
cardiovascular pathologies by its very potent antioxidant action [11].
CONCLUSION
The findings of this study strongly support the fact that the fruit of 
W. coagulans fruit (Paneer poo) may be used as a potent, natural, plant-
based, non-toxic, adjunct hypoglycemic agent in the management of 
diabetes. The bioactive components in the fruit may be extracted and 
used by the pharmaceutical industry for preparing plant-based drugs 
for diabetes that have no side effects.
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Table 1: FPG levels of subjects in the experimental and control groups
Parameter Experimental group
0th day 30th day 61st day 0th versus 30th day 30th versus 61st day 0th versus 61st day
Mean±SD Mean±SD Mean±SD “t’ Significance “t” Significance “t” Significance
FPG level 
(mg/dl)
188.75±64.93 163.33±44.77 134.08±38.58 3.64 0.004** 
(p<0.01)
3.54 0.005** (p<0.01) 3.78 0.003** (p<0.01)
Control group
181.33±67.85 169.41±45.71 207.25±60.30 1.17 0.264 NS 4.54 0.001** (p<0.01) 3.05 0.011** (p<0.01)
NS: Not significant, **Significant at p<0.01. SD: Standard deviation, FPG: Fasting plasma glucose
Table 2: Comparison of FPG levels of subjects (experimental group versus control group - 0th versus 61st day)
Parameter Experimental group versus control group










Mean±SD Mean±SD “t” Significance Mean±SD Mean±SD “t”  Significance
Fasting plasma glucose 
level (mg/dl)
188.75±64.93 181.33±67.85 0.27 0.787 NS 134.08±38.58 207.2560.30 3.54 0.002 (p<0.01)**
NS: Not significant, **Significant at p<0.01. SD: Standard deviation, FPG: Fasting plasma glucose
Fig. 4: Effect of supplementation of Withania coagulans on fasting 
plasma glucose levels of type 2 diabetic subjects
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